Study Suggests Improved Antibiotic for Golden Staph Infections

Recent findings from the SNAP Trial, published in prominent medical journals, indicate that cefazolin is a safer and equally effective alternative to flucloxacillin for treating methicillin-susceptible S. aureus bloodstream infections. The research highlights cefazolin's reduced side effects and lower risk of kidney injury. This discovery could lead to a significant change in standard clinical practice for these serious infections.